|
|
 |
|
|
|
|
| Your Result on : Balance Sheet |
|
|
|
|
| Cipla Ltd |
Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |
|
|
|
|
|
| Book Value (Rs) |
|
| 320.5640364 |
|
|
|
|
|
|
Market Cap
(Rs In Cr.) |
|
| 113,794 |
|
|
|
|
|
|
|
|
|
|
|
|
| Year |
High (Rs) |
Low (Rs) |
Close (Rs) |
P/E High |
P/E Low |
P/E Close |
Mkt Cap.
(Rs In Cr.) |
| Mar 2024 |
1,519.00 |
1,415.20 |
1,494.65 |
48.51 |
44.69 |
47.25 |
120,672.87 |
| Feb 2024 |
1,493.00 |
1,352.15 |
1,480.60 |
47.74 |
41.66 |
46.81 |
119,538.52 |
| Jan 2024 |
1,424.65 |
1,246.80 |
1,351.30 |
45.54 |
39.28 |
42.72 |
109,098.49 |
| Share Prices Of
2023
|
| Dec 2023 |
1,271.75 |
1,192.85 |
1,246.75 |
41.01 |
36.96 |
39.42 |
100,656.41 |
| Nov 2023 |
1,283.00 |
1,165.10 |
1,211.50 |
40.92 |
36.72 |
38.30 |
97,810.50 |
| Oct 2023 |
1,224.95 |
1,132.00 |
1,199.40 |
39.53 |
35.22 |
37.92 |
96,830.61 |
| Sep 2023 |
1,268.65 |
1,158.65 |
1,186.80 |
40.87 |
36.46 |
37.52 |
95,813.38 |
| Aug 2023 |
1,277.55 |
1,149.95 |
1,257.20 |
40.99 |
35.88 |
39.74 |
101,495.05 |
| Jul 2023 |
1,194.55 |
997.00 |
1,175.85 |
38.50 |
31.05 |
37.17 |
94,922.03 |
| Jun 2023 |
1,028.00 |
946.75 |
1,015.45 |
33.11 |
29.38 |
32.10 |
81,971.09 |
| May 2023 |
965.00 |
897.70 |
954.20 |
30.85 |
27.60 |
30.16 |
77,018.93 |
| Apr 2023 |
927.00 |
885.65 |
907.70 |
29.79 |
27.68 |
28.69 |
73,265.65 |
| Mar 2023 |
913.90 |
852.00 |
900.65 |
29.34 |
26.57 |
28.47 |
72,696.02 |
| Feb 2023 |
1,044.00 |
904.20 |
906.05 |
29.62 |
25.04 |
25.14 |
73,131.28 |
| Jan 2023 |
1,096.60 |
1,008.00 |
1,017.00 |
30.69 |
27.72 |
28.22 |
82,086.54 |
| Share Prices Of
2022
|
| Dec 2022 |
1,147.45 |
1,069.75 |
1,075.05 |
32.54 |
29.20 |
29.83 |
86,771.50 |
| Nov 2022 |
1,185.20 |
1,079.15 |
1,140.30 |
33.19 |
29.24 |
31.64 |
92,030.58 |
| Oct 2022 |
1,179.90 |
1,098.75 |
1,166.20 |
33.14 |
30.23 |
32.35 |
94,118.11 |
| Sep 2022 |
1,128.00 |
1,011.60 |
1,115.20 |
31.65 |
27.68 |
30.94 |
89,996.82 |
| Aug 2022 |
1,053.35 |
989.50 |
1,038.95 |
29.66 |
27.04 |
28.82 |
83,842.84 |
|
| PREV |
NEXT
|
|
|
|
|
|
|
|
|
|